However, in mammary cancer, both in malignant epithelial cells and fibroblasts, the expression of aromatase is increased via activation of promoters II and I.3, which are regulated by cyclic adenosine monophosphate (cAMP) and factors that regulate cAMP levels (26). The gene discussed is CYP19A1; the disease is breast cancer.